Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Comparison of the Safety Profile of Sickle Cell Disease Patients Treated with Hydroxycarbamide in Off-Label Versus in-Label Prescriptions in the Escort-HU Non Interventional, Prospective, Observational Open-Label Cohort Study

Ersi Voskaridou, MD, Stephan Lobitz, MD, Uwe Kordes, MD MRCP, Regine Grosse, MD, Valentine Brousse, MD, Malika Benkerrou, MD, Mariane De Montalembert, MD PhD, Jean-Antoine Ribeil, MD PhD, Frederic Galacteros, MD PhD

Blood (2016) 128 (22): 2497.

https://doi.org/10.1182/blood.V128.22.2497.2497

Published: 2016

Journal Articles

Continued Use of Tinzaparin at Therapeutic Doses for Prophylaxis of Venous Thromboembolism in Patients with Intolerance to Antivitamins K

Maria Almudena Garcia Ruiz, DOCTOR AND HEMATOLOGY SPECIALIST, Francisco Jose Romero Martinez, DOCTOR, Estefania Morente Constantin, RESIDENT, Margarita Gomez Morales, DOCTOR AND HEMATOLOGIST, Manuel Jurado, MD

Blood (2015) 126 (23): 4735.

https://doi.org/10.1182/blood.V126.23.4735.4735

Published: 2015

Journal Articles

Dominant NFKB1 Mutations Cause Antibody Deficiency and Autoinflammatory Episodes

Blood (2015) 126 (23): 206.

https://doi.org/10.1182/blood.V126.23.206.206

Published: 2015

Journal Articles

RIT with 90Y Ibritumomab Tiuxetan in Patients with Non-Hodgkin Lymphoma Over 65 Years.

Marcio M Andrade, Sr., MD, Anel Montes, MD, Ilda Murillo, MD, Jose M Grasa, Sr., MD, Teresa Baringo, MD, PhD, Pilar Giraldo, MD, PhD

Blood (2012) 120 (21): 2742.

https://doi.org/10.1182/blood.V120.21.2742.2742

Published: 2012

Journal Articles

Long-Term Efficacy and Safety Results From a Phase II Study of Ruxolitinib in Patients with Polycythemia Vera

Srdan Verstovsek, MD, PhD, Francesco Passamonti, MD, Alessandro Rambaldi, MD, Giovanni Barosi, MD, Peter J. Rosen, MD, Shui He, PhD, Nancy Contel, DVM, Bijoyesh Mookerjee, MD, FACP, Elisa Rumi, MD, Elisabetta Gattoni, MD, Lisa Pieri, MD, Mario Cazzola, MD, Hagop M. Kantarjian, MD, Tiziano Barbui, MD, Alessandro M. Vannucchi, MD

Blood (2012) 120 (21): 804.

https://doi.org/10.1182/blood.V120.21.804.804

Published: 2012

Journal Articles

A Childhood Leukaemia Cluster in Milan: Possible Role of Pandemic AH1N1 Swine Flu Virus.

Giovanni Cazzaniga, PhD, Luigi A. Bisanti, Chiara Palmi, PhD, Giorgia Randi, Fabrizio Pregliasco, Silvia Deandrea, Silvia Bungaro, Maria Grazia Valsecchi, Giuseppe Masera, Andrea Biondi, MD, Mel Greaves, MD, PhD

Blood (2012) 120 (21): 2496.

https://doi.org/10.1182/blood.V120.21.2496.2496

Published: 2012

Journal Articles

Hsa-Mir-199b-5p Targets PODXL and DDR1: Decreased Levels of Mir-199b-5p Correlate with Elevated Expressions of PODXL and DDR1 in Acute Myeloid Leukemia

Amanda Favreau, Erin Cross, Pradeep Sathyanarayana

Blood (2011) 118 (21): 1463.

https://doi.org/10.1182/blood.V118.21.1463.1463

Published: 2011

Journal Articles

The Importance of a Bone Marrow Biopsy to Distinguish Primary Immune Thrombocytopenia From Indolent Haematological Malignancies

Sif Gudbrandsdottir, MD, Hans Carl Hasselbalch, MD, DMSc, Henrik Frederiksen, MD, PhD

Blood (2010) 116 (21): 4676.

https://doi.org/10.1182/blood.V116.21.4676.4676

Published: 2010

Journal Articles

Durable Responses with the JAK1/ JAK2 Inhibitor, INCB018424, In Patients with Polycythemia Vera (PV) and Essential Thrombocythemia (ET) Refractory or Intolerant to Hydroxyurea (HU)

Blood (2010) 116 (21): 313.

https://doi.org/10.1182/blood.V116.21.313.313

Published: 2010

Journal Articles

Trisomy of Chromosome 7: a Novel Cytogenetic Abnormality in a Paediatric Case of Mixed Acute Leukemia.

Rosanna Parasole, Laura Vicari, Fara Petruzziello, Anna Leszl, Giuseppe Menna, M. Tarsitano, Luigi Del Vecchio, MD, Giulia Scalia, Giovanna Maisto, Giuseppe Basso, Vincenzo Poggi, Nicoletta Marra

Blood (2009) 114 (22): 4121.

https://doi.org/10.1182/blood.V114.22.4121.4121

Published: 2009

Journal Articles

Loss of Function of the VHL Tumor Suppressor Gene Resurrects An Endogenous Retrovirus in Kidney Cancer That Encodes a Tumor Antigen Targeted by Allogeneic T-Cells Following Hematopoietic Cell Transplantation (HCT).

Elena Cherkasova, Elizabeth Malinzak, Sheila Rao, Vera N. Senchenko, Anna V. Kudryavtseva, Lev L. Kiselev, Yoshiyuki Takahashi, MD, PhD, Nanae Harashima, W. Marston Linehan, M.D, Ramaprasad Srinivasan, MD, PhD, Michael I. Lerman, Richard W. Childs, MD

Blood (2009) 114 (22): 467.

https://doi.org/10.1182/blood.V114.22.467.467

Published: 2009

Journal Articles

Autoimmune Thrombocytopenic Purpura in a Patient with Renal Clear Cell Carcinoma

Li Xu, Shaoxu Ying, Xiao Li, MD, PhD

Blood (2008) 112 (11): 4572.

https://doi.org/10.1182/blood.V112.11.4572.4572

Published: 2008

Journal Articles

Polymorphisms in Drug Metabolism/Disposition Genes and Increased Susceptibility to Adult De Novo AML: MDR1 and CYP3A4.

Meirav Kedmi, MD, Sara B. Cohen, PhD, Deborah Rund, MD

Blood (2004) 104 (11): 2078.

https://doi.org/10.1182/blood.V104.11.2078.2078

Published: 2004

Journal Articles

Killer inhibitory receptor (CD158b) modulates the lytic activity of tumor-specific T lymphocytes infiltrating renal cell carcinomas

Nadia Guerra, Maryvonne Guillard, Eric Angevin, Hamid Echchakir, Bernard Escudier, Alessandro Moretta, Salem Chouaib, Anne Caignard

Blood (2000) 95 (9): 2883–2889.

https://doi.org/10.1182/blood.V95.9.2883.009k22_2883_2889

Published: 2000

NARROW

Comparison of the Safety Profile of Sickle Cell Disease Patients Treated with Hydroxycarbamide in Off-Label Versus in-Label Prescriptions in the Escort-HU Non Interventional, Prospective, Observational Open-Label Cohort Study

Continued Use of Tinzaparin at Therapeutic Doses for Prophylaxis of Venous Thromboembolism in Patients with Intolerance to Antivitamins K

Dominant NFKB1 Mutations Cause Antibody Deficiency and Autoinflammatory Episodes

RIT with 90Y Ibritumomab Tiuxetan in Patients with Non-Hodgkin Lymphoma Over 65 Years.

Long-Term Efficacy and Safety Results From a Phase II Study of Ruxolitinib in Patients with Polycythemia Vera

A Childhood Leukaemia Cluster in Milan: Possible Role of Pandemic AH1N1 Swine Flu Virus.

Hsa-Mir-199b-5p Targets PODXL and DDR1: Decreased Levels of Mir-199b-5p Correlate with Elevated Expressions of PODXL and DDR1 in Acute Myeloid Leukemia

The Importance of a Bone Marrow Biopsy to Distinguish Primary Immune Thrombocytopenia From Indolent Haematological Malignancies

Durable Responses with the JAK1/ JAK2 Inhibitor, INCB018424, In Patients with Polycythemia Vera (PV) and Essential Thrombocythemia (ET) Refractory or Intolerant to Hydroxyurea (HU)

Trisomy of Chromosome 7: a Novel Cytogenetic Abnormality in a Paediatric Case of Mixed Acute Leukemia.

Loss of Function of the VHL Tumor Suppressor Gene Resurrects An Endogenous Retrovirus in Kidney Cancer That Encodes a Tumor Antigen Targeted by Allogeneic T-Cells Following Hematopoietic Cell Transplantation (HCT).

Autoimmune Thrombocytopenic Purpura in a Patient with Renal Clear Cell Carcinoma

Polymorphisms in Drug Metabolism/Disposition Genes and Increased Susceptibility to Adult De Novo AML: MDR1 and CYP3A4.

Killer inhibitory receptor (CD158b) modulates the lytic activity of tumor-specific T lymphocytes infiltrating renal cell carcinomas

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only